Quan Joanne
CHIEF MEDICAL OFFICER
Quan Joanne has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Mar 17, 2026.
On the most recent filing, Quan Joanne is listed as CHIEF MEDICAL OFFICER at Mirum Pharmaceuticals, Inc. Inside the rolling window, Quan Joanne reported no open-market purchases and 3 open-market sales totaling $1.5M in MIRM. The largest disclosed transaction in the window is a sale of 7,287 MIRM shares on Mar 16, 2026, worth $670K.
Companies traded
Other insiders at MIRM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.5M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Quan Joanne made?
Quan Joanne has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Quan Joanne trade?
Quan Joanne has filed SEC Form 4 disclosures for 1 company, including MIRM.
When was Quan Joanne's most recent SEC Form 4 filing?
Quan Joanne's most recent SEC Form 4 filing on Tracefour is dated Mar 17, 2026.
What is Quan Joanne's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Quan Joanne is listed as CHIEF MEDICAL OFFICER.
What is Quan Joanne's total buy and sell value in the current window?
Inside the rolling retention window, Quan Joanne bought $0 and sold $1.5M based on SEC Form 4 filings.
What was Quan Joanne's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,287 MIRM shares on 2026-03-16, worth $670K, per SEC Form 4 filings.